C. J. Leumann et al.
Compound 8a:
A
solution of 7a (2.23 g, 4.0 mmol) in dry CH2Cl2
1H; C3’), 4.33–4.28 (m, 1H; C5’H), 4.17–4.10 (m, 2H; C4’H, C5’H),
1.17–0.94 (m, 28H; iPr); 13C NMR (75 MHz, CDCl3, 258C): d =141.2,
140.68, 137.69, 136.81, 136.80 (5s, ArC), 130.81, 128.80, 127.44, 127.30,
127.12, 126.89, 126.43, 124.08, 118.10 (9d, ArC, ImC), 87.64 (d, C2’),
82.89 (d, C1’), 82.12 (d, C4’), 69.21 (d, C3’), 60.72 (t, C5’), 17.48, 17.36,
17.34, 17.27, 17.08, 16.98, 16.90 (7q, iPr), 13.37, 13.05, 12.89, 12.67 (4d,
CH-iPr); LSIMS: m/z (%): 639 (38) [M+H]+, 511 (10), 467 (8), 261 (75),
233 (100).
(40 mL) was cooled to ꢀ788C and treated with BBr3 (1m in CH2Cl2,
14.0 mL, 14.0 mmol). After 4 h at ꢀ788C the reaction mixture was
quenched with MeOH (45 mL) and allowed to warm up to RT over
night. The solvent was evaporated; the residue dissolved in MeOH
(200 mL) and washed with hexane (3ꢂ40 mL). The aqueous layer was
evaporated and residual water was removed by coevaporation from pyri-
dine. The crude product (1.14 g) was dissolved in dry pyridine (44 mL)
and 1,3-dichloro-1,1,3,3-tetraiso-propyldisiloxane (1.25 mL, 4.0 mmol)
was added dropwise at 08C. After stirring for 5 h at RT the solvent was
evaporated. The residue was dissolved in saturated aqueous NaHCO3
(80 mL) and extracted with EtOAc (4ꢂ40 mL). The organic layer was
dried (MgSO4) and concentrated in vacuo.
Compound 9b: This compound was prepared as described for 9a, from
8b (139 mg, 0.262 mmol), 1,1’-thiocarbonyl diimidazole (56 mg,
0.31 mmol) in acetonitrile (1.2 mL). The residue was dissolved in EtOAc
(50 mL) and washed with saturated aqueous NaHCO3 (3ꢂ40 mL). Com-
pound 9b (120 mg, 71%) was obtained after FC (EtOAc/hexane 4:1) as
1
a white foam. Rf =0.25 (EtOAc/hexane 3:1); H NMR (300 MHz, CDCl3,
Compound 8a (761 mg, 36% over
2 steps) was obtained after FC
258C): d =8.89 (d, 3J(H,H)=1.8 Hz, 1H; ArH), 8.69 (d, 3J(H,H)=
(hexane/EtOAc 9:1) as a slightly yellow oil. Rf =0.24 (hexane/EtOAc
8:2); 1H NMR (300 MHz, CDCl3, 258C): d =7.62–7.58 (m, 4H; ArH),
7.53–7.43 (m, 4H; ArH), 7.38–7.33 (m, 1H; ArH), 4.91 (d, 3J(H,H)=
3.7 Hz, 1H; C1’H), 4.43 (t, 3J(H,H)=6.6 Hz, 1H; C3’H), 4.15–4.13 (m,
4.0 Hz, 1H; ArH), 8.45 (m, 1H; ImH), 8.43–8.42 (m, 2H; ArH), 8.07
3
3
(dd, J(H,H)=1.8, 8.0 Hz, 1H; ArH), 7.84 (dd, J(H,H)=1.8, 7.7 Hz, 1H;
ArH), 7.71 (m, 1H; ImH), 7.35–7.31 (m, 1H; ArH), 7.09 (s, 1H; ImH),
5.78 (d, 3J(H,H)=4.0 Hz, 1H; C2’H), 5.36 (s, 1H; C1’H), 4.67 (dd,
3J(H,H)=5.2, 8.8 Hz, 1H; C3’H), 4.29 (m, 1H; C5’H), 4.18–4.09 (m, 2H;
C4’H, C5’H), 1.11–0.92 (m, 28H; iPr); 13C NMR (75 MHz, CDCl3, 258C):
d=183.35 (s, C=S), 156.17, 155.72 (2s, ArC), 149.16 (d, ArC), 147.27 (d,
ArC), 136.87 (d, ImC), 136.77, 134.53, 134.29 (3d, ArC), 131.08 (d, ImC),
130.67, 123.79, 121.13 (3d, ArC), 118.04 (d, ImC), 87.08 (d, C2’), 82.17 (d,
C1’), 81.09 (d, C4’), 69.16 (d, C3’), 60.53 (t, C5’), 17.41, 17.30, 17.27,
17.22, 17.01, 16.92, 16.88, 16.84 (8q, iPr), 13.26, 12.97, 12.83, 12.61 (4d,
CH-iPr); LSIMS: m/z (%): 641 (10) [M+H]+, 531 (15), 261 (18), 235
(40), 278 (64), 252 (66), 215 (40), 181 (28), 160 (38), 105 (18).
3
2H; C5’H), 4.09–4.05 (m, 1H; C4’H), 4.02 (dd, J(H,H)=3.7, 5.9 Hz, 1H;
C2’H), 3.20–2.80 (br, 1H; HO), 1.14–1.04 (m, 28H; iPr); 13C NMR
(75 MHz, CDCl3, 258C): d =140.91 (s, ArC), 140.60 (s, ArC), 139.11 (s,
ArC), 128.75 (d, ArC), 127.26 (s, ArC), 127.17 (d, ArC), 127.11 (d, ArC),
126.27 (d, ArC), 85.26 (d, C1’), 82.46 (d, C2’), 77.30 (d, C4’), 71.62 (d,
C3’), 62.45 (t, C5’), 17.51, 17.40, 17.38, 17.33, 17.15, 17.11, 17.00 (7q, iPr),
13.42, 13.20, 12.89, 12.65 (4d, CH-iPr); MS (70 eV, EI): m/z (%): 528
(0.8) [M]+, 485 (29), 467 (15), 455 (9), 395 (7), 235 (100), 205 (29), 152
(17), 77 (9).
Compound 8b: This compound was prepared as described for 8a, from
7b (552 mg, 0.99 mmol), BBr3 (1m in CH2Cl2, 3.45 mL, 3.45 mmol) in
CH2Cl2 (10 mL). The reaction was quenched with MeOH (12 mL), the
mixture evaporated and the residue dissolved in H2O (50 mL) and
washed with CH2Cl2 (1ꢂ20 mL). The aqueous layer was evaporated and
dried by coevaporation from pyridine. To the crude product (285 mg) 1,3-
dichloro-1,1,3,3-tetraisopropyldisiloxane (0.37 mL, 0.99 mmol) in dry pyr-
idine (11 mL) was added. Compound 8b (239 mg, 46% over two steps)
was obtained after FC (EtOAc/hexane 3:8) as a slightly yellow oil. Rf =
0.26 (EtOAc/hexane 3:8); 1H NMR (300 MHz, CDCl3, 258C): d =8.71
(d, 3J(H,H)=2.2 Hz, 1H; ArH), 8.70–8.68 (m, 1H; ArH), 8.43–8.38 (m,
2H; ArH), 7.90 (dd, J(H,H)=1.9, 8.1 Hz, 1H; ArH), 7.83 (dt, J(H,H)=
1.8, 7.7 Hz, 1H; ArH), 7.32 (ddd, 3J(H,H)=1.1, 4.8, 7.4 Hz, 1H; ArH),
4.92 (d, 3J(H,H)=3.7 Hz, 1H; C1’H), 4.40 (t, 3J(H,H)=7.8 Hz, 1H;
C3’H), 4.16–4.06 (m, 3H; C4’H, C5’H), 3.99 (m, 1H; C2’H), 3.06 (d,
3J(H,H)=4.1 Hz, 1H; (HO), 1.12–1.02 (m, 28H; iPr); 1H NMR NOE
(400 MHz, CDCl3, 258C): d =4.92 (C1’H) ! 8.70 (ArH; 6.4%), 7.90
(ArH; 2.7%), 4.06 (C4’H; 4.2%), 3.99 (C2’H; 2.6%); 4.40 (C3’H) ! 8.71
(ArH; 1.1%), 7.90 (ArH; 2.2%), 3.99 (C2’H; 10.7%); 3.99 (C2’H) !
8.70 (ArH; 2.2%), 7.91 (ArH, 1.5%), 4.91 (C1’H; 3.2%), 4.41 (C3’H;
10.0%); 4.06 (C4’H) ! 4.92 (C1’H; 3.6%), 4.40 (C3’H; 2.5%); 13C NMR
(101 MHz, CDCl3, 258C): d =155.73 (s, ArC), 155.42 (s, ArC), 148.95 (d,
ArC), 146.91 (d, ArC), 136.81 (d, ArC), 135.48 (s, ArC), 134.27 (d, ArC),
123.53 (d, ArC), 121.01 (d, ArC), 120.63 (d, ArC), 83.09 (d, C1’), 82.70
(d, C2’), 76.53 (d, C4’), 71.57 (d, C3’), 62.29 (t, C5’), 17.31, 17.20, 17.18,
17.14, 16.94, 16.91, 16.89, 16.78 (8q, iPr), 13.20, 13.01, 12.74, 12.46 (4d,
CH-iPr); LSIMS: m/z (%): 531 (100) [M+H]+, 199 (19), 185 (28), 133
(14).
Compound 10a: A solution of 9a (700 mg, 1.1 mmol) in toluene (7.2 mL)
was heated at 808C, and a solution of Bu3SnH (0.58 mL, 2.19 mmol) and
a,a’-azobisisobutyronitrile (34 mg, 0.21 mmol) in toluene (18 mL) was
added dropwise over a period of 2 h. The reaction mixture was stirred for
2 h at 808C and then allowed to cool to RT. The mixture was concentrat-
ed in vacuo. Compound 10a (438 mg, 78%) was obtained after FC
(hexane/EtOAc 15:0.3) as a colorless oil. Rf =0.61 (hexane/EtOAc 8:2);
1H NMR (300 MHz, CDCl3, 258C): d =7.62–7.58 (m, 4H; ArH), 7.48–
7.34 (m, 5H; ArH), 5.17 (t, 3J(H,H)=7.35 Hz, 1H; C1’H), 4.60 (m, 1H;
C3’H), 4.19 (m, 1H; C5’H), 3.96–3.90 (m, 2H; C4’H, C5’H), 2.48–2.40
(m, 1H; C2’H), 2.20–2.11 (m, 1H; C2’H), 1.14–1.07 (m, 28H; iPr);
13C NMR (75 MHz, CDCl3, 258C): d =141.09, 140.93, 140.44 (3s, ArC),
128.71, 127.19, 127.11, 127.06, 126.29 (5d, ArC), 86.46 (d, C4’), 78.84 (d,
C1’), 73.43 (d, C3’), 63.76 (t, C5’), 43.11 (t, C2’), 17.59, 17.46, 17.44, 17.39,
17.26, 17.11, 17.08, 16.99 (8q, iPr), 13.52, 13.40, 13.03, 12.57 (4d, CH-iPr);
MS (70 eV, EI): m/z (%): 512 (0.02) [M]+, 469 (86), 451 (19), 439 (5), 235
(100).
3
3
Compound 10b: This compound was prepared as described for 10a.
Bu3SnH (80 mL, 0.30 mmol) and a,a’-azobisisobutyronitrile (4.6 mg,
28 mol) in toluene (0.4 mL) were added to 9b (119 mg, 0.186 mmol) in
toluene (2 mL). Compound 10b (69 mg, 72%) was obtained after FC
(EtOAc/hexane/TEA 1:3:0.05) as a slightly yellow oil. Rf =0.36 (EtOAc/
hexane 1:3); 1H NMR (300 MHz, CDCl3, 258C): d =8.67 (d, 3J(H,H)=
4.0 Hz, 1H; ArH), 8.62 (d, 3J(H,H)=1.5 Hz, 1H; ArH), 8.39 (d,
3J(H,H)=4.8 Hz, 1H; ArH), 8.36 (d, 3J(H,H)=5.2 Hz, 1H; ArH), 7.84–
7.77 (m, 2H, ArH), 7.31–7.27 (m, 1H; ArH), 5.18 (t, 3J(H,H)=7.4 Hz,
1H; C1’H), 4.56 (m, 1H; C3’H), 4.15 (m, 1H; C5’H), 3.97–3.87 (m, 2H;
C4’H, C5’H) 2.45 (ddd, 2,3J(H,H)=4.8, 7.0, 12.5 Hz, 1H; C2’H), 2.15–2.03
(m, 1H; C2’H), 1.09–1.03 (m, 28H; iPr); 13C NMR (75 MHz, CDCl3,
Compound 9a: 1,1’-Thiocarbonyl diimidazole (300 mg, 1.7 mmol) was
added to
a solution of 8a (740 mg, 1.40 mmol) in dry acetonitrile
258C):
d =156.23, 155.72 (2s, ArC), 149.35, 147.33, 137.85, 137.05,
(6.1 mL). After stirring for 9 h at RT a second portion of 1,1’-thiocarbon-
yl diimidazole (150 mg, 0.85 mmol) was added and stirred for another
9 h. The suspension was concentrated in vacuo, the residue dissolved in
CH2Cl2 (100 mL) and washed with saturated aqueous NaHCO3 solution
(3ꢂ40 mL). The organic layer was dried (MgSO4) and concentrated in
vacuo. Compound 9a (751 mg, 84%) was obtained after FC (hexane/
EtOAc 7:3) as a white solid. Rf =0.41 (hexane/EtOAc 7:3); m.p. 112–
1168C; 1H NMR (300 MHz, CDCl3, 258C): d =8.54 (s, 1H; ImH), 7.76
(s, 1H; ImH) 7.64–7.59 (m, 6H; ArH), 7.46 (t, 3J(H,H)=7.35 Hz, 2H;
ArH), 7.39–7.35 (m, 1H; ArH), 7.16 (s, 1H; ImH), 5.84 (d, 3J(H,H)=
4.8 Hz, 1H; C2’H), 5.32 (s, 1H; C1’H), 4.71 (dd, 3J(H,H)=4.8, 8.8 Hz,
134.55, 123.81, 121.24, 120.96 (8d, ArC), 86.81 (d, C4’), 77.62 (d, C1’),
73.47 (d, C3’), 63.79 (t, C5’), 43.21 (t, C2’), 17.76, 17.64, 17.61, 17.56,
17.43, 17.27, 17.16, 16.06 (8q, iPr), 13.80, 13.69, 13.58, 13.24 (4d, CH-iPr);
LSIMS: m/z (%): 515 (100) [M+H]+, 183 (20).
Compound 1a: NEt3·3HF (1.0 mL, 6.3 mmol) was added dropwise to a
solution of 10a (323 mg, 0.63 mmol) in dry THF (32 mL). After stirring
for 15 h at RT the reaction mixture was concentrated in vacuo. Com-
pound 1a (167 mg, 98%) was obtained after FC (EtOAc/toluene/MeOH
5:5:0.3) as
a white solid. Rf =0.37 (EtOAc/toluene/MeOH 5:5:1);
1H NMR (300 MHz, [D]methanol, 258C): d=7.65–7.60 (m, 4H; ArH),
1920
ꢀ 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2005, 11, 1911 – 1923